TrialCancer medicine2020

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.

Victor M Villalobos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.